Recent work on NSCLC has investigated whether the TCR repertoire enables assessment of T cell diversity and T cell clonal expansion and indicated that EGFR mutant tumors exhibits lower T cell clonal expansion (49, 50). This evidence concerns the gene EGFR and non-small cell lung carcinoma.